Suppr超能文献

外科病理学病例审核:美国病理学家学会 Q-Probes 研究的 45 家实验室

Surgical pathology case reviews before sign-out: a College of American Pathologists Q-Probes study of 45 laboratories.

机构信息

Department of Pathology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.

出版信息

Arch Pathol Lab Med. 2010 May;134(5):740-3. doi: 10.5858/134.5.740.

Abstract

CONTEXT

To avoid errors many surgical pathology services mandate review of a case by a second pathologist before reports are released (signed out).

OBJECTIVE

To study the extent and characteristics of such review.

DESIGN

Participants retrospectively examined up to 400 cases to identify a maximum of 30 cases reviewed by at least one additional pathologist before sign-out. For each case, participants documented the organ system, primary disease type, number of additional pathologists consulted, and the reason for case review. The main outcome measure was the fraction of surgical pathology cases that underwent second pathologist review before sign-out.

RESULTS

From 45 laboratories, examination of 18 032 surgical pathology cases yielded 1183 (6.6%) cases that had been reviewed before sign-out. The median laboratory reviewed 8.2% of cases. Three-fifths of reviews focused on 4 organ systems: gastrointestinal (20.5%), breast (16.0%), skin (12.7%), and female genital tract (10.0%). Malignant neoplasm far exceeded all other categories of disease in reviewed cases (45.3%). Cases were reviewed by one additional pathologist 78% of the time. Two dominant reasons for case review emerged: difficult diagnosis (46.2%) and audit required by departmental policy (43.0%). Most laboratories (71%) had departmental policies regarding review of cases. These laboratories reviewed cases about 33% more often than laboratories without policies (9.6% versus 6.5%).

CONCLUSIONS

Review of selected surgical pathology cases before sign-out is widely accepted with 71% of participant laboratories following policies to this effect. About 1 case in 15 (6.6%) were reviewed with the median laboratory of participants reviewing about 1 in 12 (8.2%).

摘要

背景

为避免错误,许多外科病理学服务机构要求在发布报告(签字)之前由第二位病理学家审查病例。

目的

研究这种审查的范围和特点。

设计

参与者回顾性地检查了多达 400 例病例,以确定在签字前至少有一位额外的病理学家审查的最多 30 例病例。对于每例病例,参与者记录了器官系统、主要疾病类型、咨询的额外病理学家数量以及病例审查的原因。主要观察指标是在签字前进行第二病理学家审查的外科病理学病例的比例。

结果

从 45 个实验室中,检查了 18032 例外科病理学病例,其中 1183 例(6.6%)在签字前进行了审查。中位数实验室审查了 8.2%的病例。五分之三的审查集中在 4 个器官系统:胃肠道(20.5%)、乳房(16.0%)、皮肤(12.7%)和女性生殖器官(10.0%)。恶性肿瘤远远超过了审查病例中的所有其他疾病类别(45.3%)。病例由一位额外的病理学家审查的时间占 78%。出现了两个主要的病例审查原因:诊断困难(46.2%)和部门政策要求的审核(43.0%)。大多数实验室(71%)都有关于审查病例的部门政策。这些实验室审查病例的频率比没有政策的实验室高约 33%(9.6%比 6.5%)。

结论

在签字前审查选定的外科病理学病例已被广泛接受,71%的参与实验室都遵循了这一政策。约每 15 例(6.6%)中有 1 例被审查,参与者中位数实验室每 12 例(8.2%)中有 1 例被审查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验